Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02841189Not ApplicableCompleted

King Vision Video Laryngoscope Ambu (aBlade) System for Use in Children

Role: collaborator

NCT03685968Not ApplicableCompleted

King Vision® and GlideScope® in Difficult Airways

Role: collaborator

NCT00602979Not ApplicableCompleted

Comparison Study in Adult Surgical Patients of 5 Airway Devices

Role: collaborator

NCT01635660Not ApplicableCompleted

Out-of-Hospital Randomized Comparison of Video-assisted Endotracheal Intubation

Role: collaborator

All 4 trials loaded